Home
Home

T-DM1

Roche Leads Pack for Upcoming FDA Approvals

Roche Leads Pack for Upcoming FDA Approvals
Motley Fool

Keep an Eye on These Five New Drugs in the First Quarter of 2013

Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville

ImmunoGen Is Living Life in the Fast Lane

ImmunoGen Is Living Life in the Fast Lane
Motley Fool

Blockbuster buzz: 15 top therapies in late-stage development

Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech

ImmunoGen Rises On Partner Roche’s Results

ImmunoGen Rises On Partner Roche’s Results
Bloomberg

Roche Drug ‘Significantly’ Extended Lives In Cancer Trial

Roche Drug ‘Significantly’ Extended Lives In Cancer Trial
Bloomberg

Analysts: Roche's armed antibody will help drive breast cancer drug sales

Analysts: Roche's armed antibody will help drive breast cancer drug sales
Fierce Biotech

Protesters push FDA on breast cancer drug at BIO conference

Protesters push FDA on breast cancer drug at BIO conference
Bizjournals.com

ImmunoGen rises on breast cancer drug data; says Roche plans 3 more T-DM1 studies in 2013

ImmunoGen rises on breast cancer drug data; says Roche plans 3 more T-DM1 studies in 2013
Yahoo/AP

Study: 'Smart bomb' drug attacks breast cancer

Study: 'Smart bomb' drug attacks breast cancer
Yahoo/AP